期刊文献+

牦牛白细胞介素2(IL2)基因cDNA的分子克隆和表达研究(英文) 被引量:3

Molecular Cloning and Expression of IL2 cDNA from Yak
下载PDF
导出
摘要 目的克隆牦牛免疫基因并研究其免疫特性。方法以伴刀豆球蛋白A(Con A)激活的体外培养的牦牛血液淋巴细胞,提取激活淋巴细胞的总RNA,用RT-PCR方法,从中克隆出白细胞介素2 cDNA,连接到T载体上测序,并亚克隆到pGEX4T-1表达质粒,在大肠杆菌进行了重组表达,纯化融合表达YIL2产物,MTT比色法测定其体外刺激牦牛血液淋巴母细胞增殖的免疫活性。结果YIL2 cDNA序列分析显示:在其编码区442位点的一个碱基发生突变(由C突变为T),从而导致终止密码子(TAA)出现,使YIL2蛋白表达提前终止,与其它牛IL2蛋白相比少了8个氨基酸。MTT比色法测定结果表明重组牦牛IL2蛋白体外能显著促进牦牛淋巴母细胞的增殖。结论本实验成功克隆了牦牛IL2基因,其原核表达产物具有显著的免疫活性,这为研制新型免疫增强剂来提高牦牛对各种疾病的抵抗力,增强牦牛疫苗的免疫保护率奠定了基础。 Objective To study the inmaune genes and their inmaunological bioactivity of Yak. Method The experiment was conducted to clone of interleukin 2 gene (IL2) of yak. The cDNA of IL2 was firstly synthesized by RT-PCR from total RNA extracted from the Concanavalin A activated lymphoeytes of yak blood and ligated into pMD-18 T vector and sequenced. The yak IL2 cDNA was then subcloned into pGEX 4T-1 and induced to express IL2 in prokaryotic cell by IPTG, which was analyzed by SDS-PAGE and the proliferation of lymphoblasts of yak. Result The sequencing analysis showed that a base mutation of C to T at position 442 of YIL2 coding region has produced a terminator (TAA), resulting in YIL2 protein to be shortened by 8 amino acids compared with other reported bovine IL2. Afterwards, the bioactivity of expression products of YIL2 cDNA was evaluated by detecting the proliferation of lymphoblasts of yak in vitro through MTT colorimetry, and the result indicated that this YIL2 protein could significantly promote the proliferation of Concanavalin A-stimulated lymphoblasts of yak. Conclusion The successful cloning and expression of yak IL2 gene is putatively useful for the development of novel inmaunopotentiator to raise the inmaunity of yak against various infectious pathogens and the inmauno-protective efficacy of vaccinations.
出处 《四川动物》 CSCD 北大核心 2005年第4期507-512,共6页 Sichuan Journal of Zoology
基金 国家自然科学基金(30170703)资助课题
关键词 牦牛 白细胞介素2基因 克隆 原核表达 生物活性 yak IL2 gene cloning prokaryotic expression bioactivity
  • 相关文献

参考文献2

二级参考文献28

  • 1Wondimu A, Veit M, Kohn B. Molecular cloning expression and characterization of the canis familiaris interleukin-4[J]. Cytokine,2001 ; 16(3) :88-92. 被引量:1
  • 2Raz E, Watanabe A, Baird S M et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Nalt Acad Sci USA,1993;90:4523-4534. 被引量:1
  • 3Kuasakabe K I,Xiu K Q,Katoh H et al. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1 specific NA vaccine[J].J Immunol 2000; 164(6) :3102-3111. 被引量:1
  • 4Homef M W, Noll A, Schirmbeck R et al. DNA vaccination using coexpression of cytokine genes with a bacterial gene encoding a 60-kD heat shock protein. Med Microbiol Immunol(Berl),2000; 189(2) : 97-104. 被引量:1
  • 5Park E K,Soh B Y,Jang Y S et al. Immune induction and modulation in mice following immunization with DNA encoding F protein of respiratory[j]. Mol Cells,2001;12(1) :50-56. 被引量:1
  • 6Woods J M, Katschke K J, Volin M V et al. IL-4 adenoviral gene therapy reduces inflammation,proinflammatory cytokines,vascularization,and bony destruction in rat adjuvant-induced arthritis[J]. J Immunol, 2001; 166(2) : 1214-1222. 被引量:1
  • 7Ko K S, Lee M, Koh J J et al. Combined administration of plasmids enocoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice[J]. Mol Ther,2001 ;4(4) :313-316. 被引量:1
  • 8Wolfe T, Bot A, Hughes A et al. Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety[J]. Eur J Immunol20(12;32(1) : 113-121. 被引量:1
  • 9Chang Y, Prud' homme G J. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgGl or IL-4/IgGl chimeric proteins protects from autoimmunity[ J]. J Gene Med, 1999; 1 (6) :415-423. 被引量:1
  • 10Kimura M, Tagawa M, Takenage K et al.Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 of interleakin-4 in nude mice: a potentiality for cancer gene therapy[J].Cancer Letters, 1998; 128(1) :47-53. 被引量:1

共引文献14

同被引文献31

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部